ClinGen Dosage Sensitivity Curation Page

9q32 population region (DGV_Gold_Standard_June_2021_gssvG40321)

  • Curation Status: Complete
  • id: ISCA-46636
  • Date last evaluated: 2021-08-05
  • Issue Type: ClinGen Region Curation
  • ClinGen Haploinsufficiency Score: 0
  • ClinGen Triplosensitivity Score: Triplosensitivity unlikely


Location Information

  • 9q32
  • GRCh37/hg19 chr9: 117,078,800-117,098,147
  • View: NCBI | Ensembl | UCSC

GRCh37/hg19 chr9: 117,078,800-117,098,147 ()

  • Haploinsufficiency score: 0
  • Strength of Evidence (disclaimer): No evidence for dosage pathogenicity
  • Triplosensitivity score: Triplosensitivity unlikely
  • Strength of Evidence (disclaimer): Triplosensitivity unlikely

Triplosensitivity phenotype comment:

As part of an effort to identify genomic regions that are unlikely to be dosage sensitive, ClinGen queried the Database of Genomic Variants (DGV) gold standard GRCh37 data set (PMID: 24174537) (downloaded June 2021) for variants meeting the following criteria: passed DGV quality filters, characterized as either a deletion or duplication, >1 kb in size, includes at least one gene, and present at an allele frequency of >5% (with at least 2000 alleles tested). This region corresponds to a variant identified as meeting those criteria in DGV gold standard GRCh37; the DGV gold standard GRCh37 identifier for this variant is reflected in the title for reference. As of July 1st, 2021, there has been no reported relationship between the gene(s) included in this region and human disease. Given the high population frequency, this region has been classified as ?dosage sensitivity unlikely?.